3181-38-2,
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diyl diacetate,
2',3',5'-Tri-O-acetylinosine,
2',3',5'-TRIACETYLINOSINE,
O2',O3',O5'-tri-acetylinosine,
Inosine 2',3',5'-triacetate,
Inosine triacetate,
C16H18N4O8,
AK115001,
EINECS 221-669-7,
AI3-52250,
AC1Q6MWG,
AC1L3W6N,
SCHEMBL597993,
2',3',6'-TAc-Ino,
SFEQTFDQPJQUJM-XNIJJKJLSA-N,
KS-00000N9J,
ZINC9013130,
MFCD00038617,
AKOS016010260,
MCULE-3704989643,
AJ-59346,
AS-12276,
SC-62276,
AX8007899,
SR-01000005768,
J-700335,
SR-01000005768-1,
9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-9H-purin-6-ol,
[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methyl acetate,
inosine, 2',3',5'-triacetate,
CID96313,
NSC90329,
AR-1J2395,
C16-H18-N4-O8,
2',3',5'-Tri-O-acetylinosine, 98% - 1G 1g,
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diyldiacetate,
33024-58-7,